Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of CD19 monoclonal antibody, clone BU12
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | Flow Cyt |
More info about CD19 monoclonal antibody, clone BU12
| Brand: | Abnova |
| Reference: | MAB6901 |
| Product name: | CD19 monoclonal antibody, clone BU12 |
| Product description: | Mouse monoclonal antibody raised against native CD19. |
| Clone: | BU12 |
| Isotype: | IgG1 |
| Gene id: | 930 |
| Gene name: | CD19 |
| Gene alias: | B4|MGC12802 |
| Gene description: | CD19 molecule |
| Immunogen: | Native purified CD19 from human EB-4 Burkitt lymphoma cell line . |
| Form: | Liquid |
| Recommend dilutions: | The optimal working dilution should be determined by the end user. |
| Storage buffer: | In 50 mM sodium phosphate buffer, 100 mM potassium Chloride, 150 mM NaCl, pH 7.5 (0.5 mg/mL gentamicin sulfate) |
| Storage instruction: | Store at 4°C. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | 5 X 105 cultured Raji cells were washed and incubated 45 minutes on ice with 80 uL of CD19 monoclonal antibody, clone BU12 (Cat # MAB6901) at 10 ug/mL. Cells were washed twice and incubated with Goat anti-Mouse IgG/FITC, after which they were washed three times, fixed and analyzed using a BD FACstar plus. Cells stained positive with a mean shift of 1.58 log10 fluorescent units when compared to a Mouse IgG1 negative control at a similar concentration. |
| Applications: | Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.Fearon DT, Carter RH. Annu Rev Immunol. 1995;13:127-49. |